MAPT and Alzheimer disease: Plasma angiostatin levels had a positive correlation with CSF t-tau/Aβ42 (R2 = 0.3932, p = 0.0164) in AD APOE-ε4 carriers but showed no correlation with CSF p-tau/Aβ42 (p = 0.8685) (Fig. 3E, F).